KRAS G12C inhibitor 16

CAS No. 2349392-79-4

KRAS G12C inhibitor 16( —— )

Catalog No. M32985 CAS No. 2349392-79-4

KRAS G12C inhibitor 16 is a potent inhibitor of KRAS G12C.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 695 Get Quote
5MG 1007 Get Quote
10MG 1349 Get Quote
25MG 1950 Get Quote
50MG 2558 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    KRAS G12C inhibitor 16
  • Note
    Research use only, not for human use.
  • Brief Description
    KRAS G12C inhibitor 16 is a potent inhibitor of KRAS G12C.
  • Description
    KRAS G12C inhibitor 16 is a potent KRAS G12C inhibitor extracted from patent WO2019110751A1, compound 39, has an IC50 of 97 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Kras
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2349392-79-4
  • Formula Weight
    453.89
  • Molecular Formula
    C24H21ClFN3O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1=C2C(C=3N4[C@](CN(C(C=C)=O)CC4)(COC3C=N2)[H])=CC(Cl)=C1C5=C(F)C=CC=C5O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Jason Grant Kettle, et al. Tetracyclic compounds as inhibitors of g12c mutant ras protein, for use as anti-cancer agents. WO2019110751A1.
molnova catalog
related products
  • Azo Rubine

    Azo Rubine is a food dye Azorubine?and is used for the purposes where food is heat-treated after fermentation.

  • Elezanumab

    Elezanumab(ABT-555) is a potent human anti-RGMa monoclonal antibody.Elezanumab exerts its inhibitory effect on RGMa-mediated BMP signaling through the SMAD1/5/8 pathway, with an IC50 of approximately 97 pM.

  • Mofebutazone

    Mofebutazone inhibits the immunological release of prostaglandins as well as leukotrienes.